1. The inhibition of RANKL-induced osteoclastogenesis through the suppression of p38 signaling pathway by naringenin and attenuation of titanium-particle-induced osteolysis
- Author
-
Xuqiang Liu, Tingting Tang, Chuanlong Wu, Chuan Jiang, Bo Tian, Zhenan Zhu, Yuanqing Mao, An Qin, Xinhua Qu, Zanjing Zhai, Zhengxiao Ouyang, and Wengang Wang
- Subjects
Naringenin ,Osteolysis ,Osteoclasts ,NFATc1 ,p38 Mitogen-Activated Protein Kinases ,lcsh:Chemistry ,chemistry.chemical_compound ,Osteogenesis ,Extracellular Signal-Regulated MAP Kinases ,lcsh:QH301-705.5 ,Spectroscopy ,Titanium ,p38 signaling ,biology ,Cell Death ,Chemistry ,NF-kappa B ,food and beverages ,Cell Differentiation ,General Medicine ,Computer Science Applications ,medicine.anatomical_structure ,RANKL ,Flavanones ,osteoclast ,medicine.symptom ,Anisomycin ,medicine.medical_specialty ,MAP Kinase Signaling System ,naringenin ,Models, Biological ,Catalysis ,Bone resorption ,Article ,Inorganic Chemistry ,In vivo ,Osteoclast ,Internal medicine ,medicine ,Animals ,Humans ,Physical and Theoretical Chemistry ,Bone Resorption ,Molecular Biology ,NFATC Transcription Factors ,Organic Chemistry ,RANK Ligand ,JNK Mitogen-Activated Protein Kinases ,medicine.disease ,NFKB1 ,Actins ,Mice, Inbred C57BL ,Endocrinology ,lcsh:Biology (General) ,lcsh:QD1-999 ,Mechanism of action ,Gene Expression Regulation ,biology.protein ,Cancer research - Abstract
The aim of this study was to assess the effect of naringenin on osteoclastogenesis and titanium particle-induced osteolysis. Osteolysis from wear-induced particles and aseptic loosening are the most frequent late complications of total joint arthroplasty leading to revision of the prosthesis. Osteolysis during aseptic loosening is most likely due to increased bone resorption by osteoclasts. Through in vitro studies, we demonstrated that naringenin, a naturally occurring flavanone in grapefruit and tomatoes, exerts potent inhibitory effects on the ligand of the receptor activator of nuclear factor-κB (RANKL)-induced osteoclastogenesis and revealed that the mechanism of action of naringenin, which inhibited osteoclastogenesis by suppression of the p38 signaling pathway. Through in vivo studies, we proved that naringenin attenuated titanium particle-induced osteolysis in a mouse calvarial model. In general, we demonstrated that naringenin inhibited osteoclastogenesis via suppression of p38 signaling in vitro and attenuated titanium particle-induced osteolysis in vivo. This study also suggested that naringenin has significant potential for the treatment of osteolysis-related diseases caused by excessive osteoclast formation and activity.
- Published
- 2014